clinical trial · NCT07143513
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
Amgen·—·completed·n = 102
Non-Small Cell Lung CancerSotorasib
brief summary
The primary objective of this study is to characterize the safety profile of sotorasib.
started
Aug 11, 2025
primary completion
Dec 7, 2025
completion
Dec 7, 2025
last updated
Apr 7, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol